ATMI Expands Bloomington, Minnesota Manufacturing Facility - - BioPharm International


ATMI Expands Bloomington, Minnesota Manufacturing Facility

ATMI, Inc. has established a North American hub for the production, marketing, and development of its single-use technologies for biopharmaceutical and other life sciences applications by expanding its Bloomington, MN manufacturing facility. The North American site was launched at an official ribbon-cutting ceremony on July 28, 2010.

The added capabilities double ATMI's worldwide capacity for ATMI LifeSciences' Integrity product line of 2-D and 3-D transfer, storage, mixing, and bioreactor vessels, while adding supply chain contingency through a dual-manufacturing capability shared with existing manufacturing plant in Hoegaarden, Belgium.

"Creating a copy-exact of our Belgian facility for change management and supply chain security reasons also helped us to quickly replicate cGMP procedures," said ATMI CEO and President Doug Neugold.

Featuring a 2,500 sq. ft. Class 1000 cleanroom with Class 100 work areas, the additions also include a new demonstration and applications laboratory and a separate product development laboratory. The production area has a dedicated space to perform 100% integrity testing of each fully assembled vessel, including bioburden, weld strength, and particle contamination monitoring.

"Increasing our manufacturing footprint addresses the rapidly increasing demands of the biopharmaceutical marketplace for single-use vessels applications in the field of storage, mixing and bioreactors," said Mario Philips, senior vice president and general manager of ATMI LifeSciences.

blog comments powered by Disqus



GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
Author Guidelines

Click here